Table 2 Activation Likelihood Estimation (ALE) analyses on the effects of antidepressants in major depressive disorder.
Experiments | Comparison | N | Min pcFWEa | Convergence |
---|---|---|---|---|
All | All | 30 | 0.387 | - |
Treated > Untreated | 20 | 0.005 | L DLPFC | |
Treated < Untreated | 21 | 0.615 | - | |
Based on modality | ||||
Rest | All | 12 | 0.052 | - |
Task | All | 19 | 0.970 | - |
Based on treatment and clinical setting | ||||
Excluding ketamine | All | 23 | 0.486 | - |
Treated > Untreated | 14 | 0.024 | L DLPFC, R DLPFC | |
Treated < Untreated | 16 | 0.464 | - | |
Pre- versus post-treatment effects | All | 24 | 0.294 | - |
Treated > Untreated | 18 | 0.004 | L DLPFC, R DLPFC | |
Treated < Untreated | 20 | 0.469 | - | |
Treatment duration > 4 weeks | All | 20 | 0.472 | - |
Treated > Untreated | 12 | 0.010 | R mSFG | |
Treated < Untreated | 14 | 0.189 | - | |
Response in ≥50% of subjects | All | 19 | 0.614 | - |
Treated > Untreated | 12 | 0.007 | L SMG, R DLPFC | |
Treated < Untreated | 15 | 0.357 | - |